Vaccine comprising an angiomotin or a polynucleotide encoding an angiomotin and its uses for the treatment of angiogenic-related disorders

Details for Australian Patent Application No. 2004303504 (hide)

Owner Bioinvent International AB

Inventors Kiessling, Rolf; Holmgren, Lars

Agent Griffith Hack

Pub. Number AU-A-2004303504

PCT Pub. Number WO2005/061538

Priority 0330079.5 20.12.03 GB

Filing date 20 December 2004

Wipo publication date 7 July 2005

International Classifications

A61K 39/00 (2006.01) Medicinal preparations containing antigens or antibodies

C07K 14/71 (2006.01) Peptides having more than 20 amino acids

Event Publications

6 July 2006 PCT application entered the National Phase

  PCT publication WO2005/061538 Priority application(s): WO2005/061538

31 August 2006 Change of Name(s) of Applicant(s), Section 104

  Bioinvent International AB The name of the applicant has been changed to BioInvent International AB

15 July 2010 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(d). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004303506-Method for the production of substituted 2-(phenoxymethyl)-benzoic acids

2004303495-Low-alcohol beer or beer-like refreshment beverages containing palatinose